Skip to main content
Premium Trial:

Request an Annual Quote

Aushon Enters Predictive Dx Deal with Peking University

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aushon BioSystems today said that it has signed a letter of intend to collaborate with Peking University Cancer Hospital on the development of predictive diagnostic markers for liver metastases of colorectal cancer.

The collaboration will use Aushon's protein biomarker detection technologies and stratification biomarkers for radio-chemotherapy patients. The partners expect to negotiate an agreement to provide Aushon with exclusive rights in North America and Europe to certain intellectual property generated from the collaboration for diagnostic applications.

Jin Gu, a professor and clinician at PUCH, will lead the research.

"We believe Aushon's technology and expertise are ideally suited for this diagnostic development program and expect that this will be the first of several such technical collaborations with Peking University Cancer Hospital and other leading research institutions in Asia," Joe Blanchard, COO of Billerica, Mass.-based Aushon, said in a statement.

A few months ago, Aushon signed a deal with LightArray Biotech to provide the firm's multiplex biomarker products and services in China.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.